These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9537591

  • 1. Repeated treatment with antibody-targeted superantigens strongly inhibits tumor growth.
    Rosendahl A, Kristensson K, Hansson J, Ohlsson L, Kalland T, Dohlsten M.
    Int J Cancer; 1998 Apr 13; 76(2):274-83. PubMed ID: 9537591
    [Abstract] [Full Text] [Related]

  • 2. Long-term survival and complete cures of B16 melanoma-carrying animals after therapy with tumor-targeted IL-2 and SEA.
    Rosendahl A, Kristensson K, Carlsson M, Skartved NJ, Riesbeck K, Søgaard M, Dohlsten M.
    Int J Cancer; 1999 Mar 31; 81(1):156-63. PubMed ID: 10077167
    [Abstract] [Full Text] [Related]

  • 3. The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens.
    Litton MJ, Dohlsten M, Rosendahl A, Ohlsson L, Søgaard M, Andersson J, Andersson U.
    Br J Cancer; 1999 Sep 31; 81(2):359-66. PubMed ID: 10496366
    [Abstract] [Full Text] [Related]

  • 4. Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo.
    Dohlsten M, Hansson J, Ohlsson L, Litton M, Kalland T.
    Proc Natl Acad Sci U S A; 1995 Oct 10; 92(21):9791-5. PubMed ID: 7568219
    [Abstract] [Full Text] [Related]

  • 5. Immune response during tumor therapy with antibody-superantigen fusion proteins.
    Rosendahl A, Hansson J, Sundstedt A, Kalland T, Dohlsten M.
    Int J Cancer; 1996 Sep 27; 68(1):109-13. PubMed ID: 8895549
    [Abstract] [Full Text] [Related]

  • 6. Perforin and IFN-gamma are involved in the antitumor effects of antibody-targeted superantigens.
    Rosendahl A, Kristensson K, Hansson J, Riesbeck K, Kalland T, Dohlsten M.
    J Immunol; 1998 Jun 01; 160(11):5309-13. PubMed ID: 9605129
    [Abstract] [Full Text] [Related]

  • 7. Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.
    Litton MJ, Dohlsten M, Hansson J, Rosendahl A, Ohlsson L, Kalland T, Andersson J, Andersson U.
    Am J Pathol; 1997 May 01; 150(5):1607-18. PubMed ID: 9137087
    [Abstract] [Full Text] [Related]

  • 8. Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer.
    Wang Q, Yu H, Zhang L, Ju D, Pan J, Xia D, Yao H, Zhang W, Wang J, Cao X.
    J Mol Med (Berl); 2002 Sep 01; 80(9):585-94. PubMed ID: 12226740
    [Abstract] [Full Text] [Related]

  • 9. Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.
    Sundstedt A, Celander M, Hedlund G.
    Int Immunopharmacol; 2008 Mar 01; 8(3):442-52. PubMed ID: 18279798
    [Abstract] [Full Text] [Related]

  • 10. Superantigens anergize cytokine production but not cytotoxicity in vivo.
    Sundstedt A, Dohlsten M, Hedlund G, Höidén I, Björklund M, Kalland T.
    Immunology; 1994 May 01; 82(1):117-25. PubMed ID: 7913912
    [Abstract] [Full Text] [Related]

  • 11. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo.
    Sundstedt A, Höiden I, Rosendahl A, Kalland T, van Rooijen N, Dohlsten M.
    J Immunol; 1997 Jan 01; 158(1):180-6. PubMed ID: 8977189
    [Abstract] [Full Text] [Related]

  • 12. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.
    Sundstedt A, Grundström S, Dohlsten M.
    Immunology; 1998 Sep 01; 95(1):76-82. PubMed ID: 9767460
    [Abstract] [Full Text] [Related]

  • 13. Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma.
    Wang Q, Yu H, Ju DW, He L, Pan JP, Xia DJ, Zhang LH, Cao X.
    Gene Ther; 2001 Apr 01; 8(7):542-50. PubMed ID: 11319621
    [Abstract] [Full Text] [Related]

  • 14. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
    Dohlsten M, Hedlund G, Akerblom E, Lando PA, Kalland T.
    Proc Natl Acad Sci U S A; 1991 Oct 15; 88(20):9287-91. PubMed ID: 1924393
    [Abstract] [Full Text] [Related]

  • 15. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.
    Litton MJ, Dohlsten M, Lando PA, Kalland T, Ohlsson L, Andersson J, Andersson U.
    Eur J Immunol; 1996 Jan 15; 26(1):1-9. PubMed ID: 8566049
    [Abstract] [Full Text] [Related]

  • 16. Immunotherapy with tumor-targeted superantigens (TTS) in combination with docetaxel results in synergistic anti-tumor effects.
    Sundstedt A, Celander M, Ohman MW, Forsberg G, Hedlund G.
    Int Immunopharmacol; 2009 Aug 15; 9(9):1063-70. PubMed ID: 19410661
    [Abstract] [Full Text] [Related]

  • 17. Repeated treatment with S. aureus superantigens expands the survival rate of Ehrlich ascites tumor bearing mice.
    Mondal TK, Bhatta D, Biswas S, Pal P.
    Immunol Invest; 2002 Feb 15; 31(1):13-28. PubMed ID: 11990460
    [Abstract] [Full Text] [Related]

  • 18. Genetically engineered superantigens as tolerable antitumor agents.
    Hansson J, Ohlsson L, Persson R, Andersson G, Ilbäck NG, Litton MJ, Kalland T, Dohlsten M.
    Proc Natl Acad Sci U S A; 1997 Mar 18; 94(6):2489-94. PubMed ID: 9122222
    [Abstract] [Full Text] [Related]

  • 19. Vaccination with IL-18 gene-modified, superantigen-coated tumor cells elicits potent antitumor immune response.
    Wang Q, Yu H, Zhang L, Ju D, Pan J, Xia D, He L, Wang J, Cao X.
    J Cancer Res Clin Oncol; 2001 Dec 18; 127(12):718-26. PubMed ID: 11768611
    [Abstract] [Full Text] [Related]

  • 20. Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells.
    Kato M, Nakamura Y, Suda T, Ozawa Y, Inui N, Seo N, Nagata T, Koide Y, Kalinski P, Nakamura H, Chida K.
    Cancer Immunol Immunother; 2011 Jul 18; 60(7):1029-38. PubMed ID: 21519830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.